Herbalife Ltd. (NYSE:HLF) Receives Consensus Rating of "Hold" from Brokerages

Shares of Herbalife Ltd. (NYSE:HLF - Get Free Report) have received a consensus recommendation of "Hold" from the five analysts that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $9.90.

A number of research firms recently commented on HLF. B. Riley decreased their price target on Herbalife from $17.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday, October 31st. Citigroup dropped their target price on shares of Herbalife from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Mizuho lifted their price target on shares of Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a report on Friday, November 1st. StockNews.com upgraded Herbalife from a "hold" rating to a "buy" rating in a research note on Monday, November 4th. Finally, DA Davidson cut their price target on shares of Herbalife from $13.00 to $7.50 and set a "neutral" rating on the stock in a report on Thursday, October 31st.

Herbalife Price Performance

HLF stock traded down $0.03 during midday trading on Tuesday, reaching $6.69. 1,663,037 shares of the company's stock traded hands, compared to its average volume of 2,184,566. Herbalife has a fifty-two week low of $6.21 and a fifty-two week high of $15.43. The business has a 50-day moving average price of $7.58 and a two-hundred day moving average price of $8.52. The company has a market capitalization of $674.30 million, a P/E ratio of 7.87, a PEG ratio of 0.27 and a beta of 1.17.

Herbalife (NYSE:HLF - Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.19 by $0.38. The business had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.23 billion. Herbalife had a negative return on equity of 18.66% and a net margin of 1.73%. As a group, research analysts forecast that Herbalife will post 1.51 earnings per share for the current fiscal year.

Institutional Trading of Herbalife

Several hedge funds have recently modified their holdings of the company. nVerses Capital LLC increased its holdings in Herbalife by 240.0% during the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company's stock valued at $53,000 after purchasing an additional 3,600 shares in the last quarter. Van ECK Associates Corp lifted its position in Herbalife by 10.3% during the 2nd quarter. Van ECK Associates Corp now owns 8,684 shares of the company's stock worth $90,000 after buying an additional 808 shares in the last quarter. Carolina Wealth Advisors LLC acquired a new stake in Herbalife in the 3rd quarter valued at about $78,000. Algert Global LLC lifted its position in shares of Herbalife by 98.9% during the second quarter. Algert Global LLC now owns 20,173 shares of the company's stock worth $210,000 after purchasing an additional 10,033 shares in the last quarter. Finally, Prospera Financial Services Inc bought a new stake in shares of Herbalife during the third quarter valued at approximately $154,000.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.